Tissue-engineered tubular substitutions for urinary diversion in a preclinical rabbit model

ObjectiveTo develop and evaluate tissue-engineered tubular constructs using homologous adipose-derived stem cells (ASCs), smooth muscle cells (SMCs), and decellularized fish swim bladder (DFSB) matrix for urinary diversion in a rabbit model.MethodsRabbit ASCs and SMCs were isolated and expanded in v...

Full description

Bibliographic Details
Published in:Frontiers in Medicine
Main Authors: Qianliang Wang, Qingling Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1616977/full
_version_ 1849631009876738048
author Qianliang Wang
Qingling Liu
author_facet Qianliang Wang
Qingling Liu
author_sort Qianliang Wang
collection DOAJ
container_title Frontiers in Medicine
description ObjectiveTo develop and evaluate tissue-engineered tubular constructs using homologous adipose-derived stem cells (ASCs), smooth muscle cells (SMCs), and decellularized fish swim bladder (DFSB) matrix for urinary diversion in a rabbit model.MethodsRabbit ASCs and SMCs were isolated and expanded in vitro; cultured cells were seeded onto bilateral surfaces of DFSB scaffolds followed by 7-day incubation; cell-seeded matrices were shaped into tubular constructs; constructs underwent 2-week in vivo pre-vascularization within omental pouches. Experimental group rabbits (n=24) underwent complete bladder resection with replacement by pre-vascularized constructs, while control group (n=6) received identical implantation of acellular DFSB tubes. Histological evaluations were conducted at postoperative weeks 2, 4, 8, and 16; intravenous urography (IVU) was performed at 16-week endpoint.ResultsAll experimental animals survived until scheduled sacrifice with histological evidence of: (1) luminal multilayer urothelium, (2) organized smooth muscle tissue on abluminal surfaces, and (3) construct-wide neovascularization of varying diameters; IVU confirmed absence of urinary leakage, stricture, or obstruction. Conversely, all control animals died within 2 weeks post-operation; autopsy revealed urine leakage, extensive scar formation, and severe inflammation as mortality causes.ConclusionTissue-engineered tubular constructs fabricated from homologous ASCs, SMCs, and DFSB scaffold demonstrate feasibility as a viable urinary diversion alternative in rabbit models, showing functional tissue regeneration and superior outcomes versus acellular controls.
format Article
id doaj-art-bc9f9affd92e41cbbf5284ccc09c8d9c
institution Directory of Open Access Journals
issn 2296-858X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
spelling doaj-art-bc9f9affd92e41cbbf5284ccc09c8d9c2025-08-20T02:24:17ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-06-011210.3389/fmed.2025.16169771616977Tissue-engineered tubular substitutions for urinary diversion in a preclinical rabbit modelQianliang Wang0Qingling Liu1Department of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, ChinaDepartment of Record Room, Affiliated Hospital of Guangdong Medical University, Zhanjiang, ChinaObjectiveTo develop and evaluate tissue-engineered tubular constructs using homologous adipose-derived stem cells (ASCs), smooth muscle cells (SMCs), and decellularized fish swim bladder (DFSB) matrix for urinary diversion in a rabbit model.MethodsRabbit ASCs and SMCs were isolated and expanded in vitro; cultured cells were seeded onto bilateral surfaces of DFSB scaffolds followed by 7-day incubation; cell-seeded matrices were shaped into tubular constructs; constructs underwent 2-week in vivo pre-vascularization within omental pouches. Experimental group rabbits (n=24) underwent complete bladder resection with replacement by pre-vascularized constructs, while control group (n=6) received identical implantation of acellular DFSB tubes. Histological evaluations were conducted at postoperative weeks 2, 4, 8, and 16; intravenous urography (IVU) was performed at 16-week endpoint.ResultsAll experimental animals survived until scheduled sacrifice with histological evidence of: (1) luminal multilayer urothelium, (2) organized smooth muscle tissue on abluminal surfaces, and (3) construct-wide neovascularization of varying diameters; IVU confirmed absence of urinary leakage, stricture, or obstruction. Conversely, all control animals died within 2 weeks post-operation; autopsy revealed urine leakage, extensive scar formation, and severe inflammation as mortality causes.ConclusionTissue-engineered tubular constructs fabricated from homologous ASCs, SMCs, and DFSB scaffold demonstrate feasibility as a viable urinary diversion alternative in rabbit models, showing functional tissue regeneration and superior outcomes versus acellular controls.https://www.frontiersin.org/articles/10.3389/fmed.2025.1616977/fulltissue engineeringadipose-derived stem cellssmooth muscle cellsdecellularized fish swim bladderepitheliumurinary diversion
spellingShingle Qianliang Wang
Qingling Liu
Tissue-engineered tubular substitutions for urinary diversion in a preclinical rabbit model
tissue engineering
adipose-derived stem cells
smooth muscle cells
decellularized fish swim bladder
epithelium
urinary diversion
title Tissue-engineered tubular substitutions for urinary diversion in a preclinical rabbit model
title_full Tissue-engineered tubular substitutions for urinary diversion in a preclinical rabbit model
title_fullStr Tissue-engineered tubular substitutions for urinary diversion in a preclinical rabbit model
title_full_unstemmed Tissue-engineered tubular substitutions for urinary diversion in a preclinical rabbit model
title_short Tissue-engineered tubular substitutions for urinary diversion in a preclinical rabbit model
title_sort tissue engineered tubular substitutions for urinary diversion in a preclinical rabbit model
topic tissue engineering
adipose-derived stem cells
smooth muscle cells
decellularized fish swim bladder
epithelium
urinary diversion
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1616977/full
work_keys_str_mv AT qianliangwang tissueengineeredtubularsubstitutionsforurinarydiversioninapreclinicalrabbitmodel
AT qinglingliu tissueengineeredtubularsubstitutionsforurinarydiversioninapreclinicalrabbitmodel